04022026: Fits schema. For the BiocatalysisPurchased the MW was included (eventhough not in paper)

Halohydrin dehalogenases (HHDHs)
is_a biocatalyst
catalyze synthesis of industrial heterocyclic compounds
catalyze synthesis of chiral alkanolamines from aromatic substrates with NaOCN
enable reactions not feasible through chemosynthesis

HHDH panel 
screened for: ability to convert aliphatic cyclohexene oxide

Best HHDH variant (whole cell)
used in: novel chemical process for pilot-scale ring-opening reactions

Best HHDH hit (whole cell)
provides: viable bio-catalytic approach for synthesis of fine chemicals

HHDHs
catalyze: reversible dehalogenation of vicinal haloalcohols
reverse reaction: non-natural nucleophiles (NaOCN, NaSCN) facilitate enzymatic SN2 ring-opening
produce: oxazolidines via ring-opening and ring-closing
accept: various non-natural nucleophiles for ring-opening

Most HHDH reactions
triggered by: nucleophiles attacking terminal position (beta-attack)

Beta-attack
results in: secondary alcohols as final products

Some HHDHs
exhibit: alpha-regioselectivity in ring-opening of styrene oxide

Alpha-regioselectivity
produces: new series of heterocyclic products

Chen et al.
reported: synthesis of 4-phenyl-2-oxazolidinone via alpha type HHDH

G-type HHDHs
catalyze: non-native ring-opening reactions of cyclohexene oxide
achieve: enantiomeric excess of 52% at 20 mM substrate concentration

HheG (from Ilumatobacter coccineus)
used for: synthesis of trans-hexahydro-2(3H)-benzoxazolone (trans-HBC)
achieves: >90% conversion and 53% ee at 10× cyclohexene oxide loading

HHDH whole cell libraries
screened for: activity towards cyclohexene oxide using NaOCN
screened: 8 diverse HHDHs active towards cyclohexene oxide

Screening
identified: 8 HHDH hits with observable reactivities

HHDHs attacking terminal carbon of styrene oxide
have no activity towards: cyclohexene oxide

HHDH from Ilumatobacter coccineus (IcHheG)
most active: among 8 HHDH hits (42% yield)
selected as: best candidate for process engineering

HheG
favors: SN2 attack on tertiary carbons in styrene oxide reactions
exhibits: tertiary carbon specificity
maintains activity: from pH 7–11

HheG (whole cell)
used as: biocatalyst for process development
tested at: 200 mM cyclohexene oxide loading

Direct contact of HHDHs and epoxides
causes: enzyme inactivation

Two-phase reactions with organic solvents
screened to: enhance substrate solubility and avoid enzyme inactivation

Ethyl acetate
determined as: most suitable solvent for enzymatic reactions (yield up to 95%)
enhances: solubility of cyclohexene oxide in water
controls: pH at 10.5 by converting NaOH to ethanol and sodium acetate

HHDH containing cell lysate
results in: 93% product yield (similar to whole cell biocatalysts)

Two-phase reaction conditions
permit: self-pH control, eliminating need for additional buffering agents

Pilot-scale manufacturing (1 L and 10 L)
applied: same reaction conditions as 50 mL scale

Pilot-scale manufacturing
achieved: 95% conversion, 87% isolated yield, 53% ee
performed in: 50 L reactor with temperature controller

Best HHDH candidate
scaled up: from analytical to pilot-scale manufacturing

New process
improved: reactivity performance by 10 fold
eliminated: obstacles such as low epoxide loading, pH control, and solubility issues
avoids: use of toxic chemicals

First case
successful upscaling of: HHDH cyanate reactions to industrial scale

HHDH catalysis
enables: enantioselective synthesis of building blocks for asymmetric molecular targets

Most HHDHs
rely on: toxic substances (e.g., sodium azide, NaBH4) for alkanolamine synthesis

New self-regulated process
uses: non-natural enzyme catalysis with OCN nucleophilic ring-opening

HHDH catalysis and chemo-hydrolysis
enables: exploration of more oxazolidinones and alkanolamines

HBC (trans-hexahydro-2(3H)-benzoxazolone)
considered as: precursor for pesticides (e.g., fenoxaprop-P-ethyl, metamifop)

HHDH route
offers: affordable approach to synthesizing heterocyclic compounds and chiral alkanolamines

HHDH genes
codon optimized for: E. coli BL21 expression system
subcloned into: pET28a in HHDH libraries

HheG expression strain
grown in: lysogeny broth-Miller culture with kanamycin

HheG expression
induced by: lactose at 30°C for 16 h

Whole cells
harvested by: centrifugation and stored at -20°C

Stored HHDH whole cells
used as: biocatalyst for all reactions

Initial screening
performed in: 96-well plates with 50 g/L wet cell, 10 mM cyclohexene oxide, 20 mM NaOCN, 200 μL PB buffer (pH 7.0) at 35°C

Enzyme activity
evaluated by: monitoring HBC formation via gas chromatography

Best hit (whole cell)
characterized in: 5 mL reactions with varying cyclohexene oxide, 2 eq NaOCN, 35% co-solvent, 16 hrs

Lysate catalysis
performed with: lysozyme pre-treatment, cyclohexene oxide, NaOCN, ethyl acetate, 16 hrs

Analytical methods
include: achiral and chiral GC analysis

Pilot-scale reaction
used: water, ethyl acetate, cyclohexene oxide, NaOCN, wet cell biocatalyst

Reaction temperature
maintained at: 25°C for 29 hrs

Post-processing
involves: ethyl acetate extraction, centrifugation, phase separation, concentration, heptane precipitation, filtration

Final product (HBC)
isolated yield: 87%
enantiomeric excess: 53%

Substrate docking
conducted using: AutoDockVina module of Yasara

HheG (PDB: 5O30)
used as: receptor for docking

Cyclohexene oxide and cyanate ion
used as: ligands for docking

Docking
identified: binding modes and nucleophile binding site in HHDH

Docking results
support: proposed SN2 mechanism and tertiary carbon specificity